glp-1 drugs fda approved for weight loss What's New in Obesity Treatment? The FDA has approved the

doi:10.1016/j.cgh.2023.08.034 70

Conceio-Furber E, Coskun T, Sloop KW, Samms RJ

Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement

In general, GLP-1 agonists promote weight loss through the following two mechanisms: Suppression of appetite and cravings: These medications target the brain to curtail appetite so one can achieve satiety with small portions of food

Despite heavy competition from more established companies, Pfizer Chief US Commercial Officer and EVP Aamir Malik said in a Feb

The updated model emphasizes that aging is not driven by a single mechanism, but emerges from a network of interacting biological systems that link molecular damage to systemic physiological decline